Breast | Ovary | Uterus | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Premenopausal | Postmenopausal | Premenopausal | Postmenopausal | Premenopausal | Postmenopausal | ||||||||||||||||
N=381 | N=603 | N=25 | N=51 | N=97 | N=108 | ||||||||||||||||
N† | RR | 95% CI | N | RR | 95% CI | Pint‡ | N | RR | 95% CI | N | RR | 95% CI | Pint | N | RR | 95% CI | N | RR | 95% CI | Pint | |
OPs | 105 | 1.02 | 0.77 to 1.36 | 174 | 1.27 | 1.00 to 1.62 | 0.81 | 9 | 1.92 | 0.67 to 5.47 | 12 | 1.09 | 0.48 to 2.51 | 0.24 | 33 | 1.41 | 0.81 to 2.45 | 33 | 0.95 | 0.55 to 1.62 | 0.52 |
Malathion | 80 | 1.04 | 0.78 to 1.38 | 132 | 1.03 | 0.81 to 1.30 | 0.44 | 8 | 2.14 | 0.78 to 5.93 | 8 | 0.57 | 0.24 to 1.33 | 0.04 | 27 | 1.47 | 0.86 to 2.49 | 26 | 0.98 | 0.58 to 1.67 | 0.33 |
Diazinon | 44 | 1.01 | 0.73 to 1.40 | 65 | 1.11 | 0.85 to 1.45 | 0.95 | 7 | 3.26 | 1.31 to 8.13 | 5 | 1.18 | 0.46 to 3.03 | 0.06 | 16 | 1.42 | 0.81 to 2.50 | 6 | 0.52 | 0.22 to 1.19 | 0.03 |
Chlorpyrifos | 20 | 1.36 | 0.79 to 2.34 | 27 | 1.53 | 0.96 to 2.44 | 0.83 | 5 | 0.75 | 0.23 to 2.42 | 5 | 1.09 | 0.36 to 3.34 | 0.92 | |||||||
Terbufos | 13 | 1.25 | 0.61 to 2.54 | 19 | 1.73 | 0.93 to 3.21 | 0.88 | ||||||||||||||
Dichlorvos | 11 | 1.07 | 0.58 to 1.97 | 22 | 1.24 | 0.80 to 1.92 | 0.79 | ||||||||||||||
Phorate | 11 | 1.44 | 0.73 to 2.84 | 10 | 0.64 | 0.31 to 1.29 | 0.10 | ||||||||||||||
Fonofos | 5 | 0.56 | 0.20 to 1.56 | 8 | 0.52 | 0.23 to 1.20 | 0.80 | ||||||||||||||
Coumaphos | 6 | 1.29 | 0.57 to 2.90 | 12 | 1.36 | 0.77 to 2.43 | 0.93 | ||||||||||||||
Parathion | 4 | 0.93 | 0.35 to 2.50 | 9 | 1.46 | 0.75 to 2.83 | 0.54 |
*Adjusted for age, race, state, pack-years smoked, family history of cancer, alcohol consumption, BMI, education, home and garden pesticide application, correlated/associated pesticide use, number of live births and oral contraceptive use.
†Exposed cases.
‡P interaction for menopausal status at enrolment and OP use.
AHS, Agricultural Health Study; OP, organophosphates; RR, relative risks.